Value through Innovation

main navigation

jump to contentto meta navigation
Press Releases

page content

jump to main navigationto meta navigation

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

back12345678910111213141516
29.04.2012 Switching to TWYNSTA® allows patients with uncontrolled hypertension on monotherapy to rapidly reach their blood pressure goals - For Non-US and Non-UK Healthcare Media Only
24.04.2012 Boehringer Ingelheim on growth path - Successful 2011 financial year
20.04.2012 GLORIA TM-AF Registry Program investigating use of antithrombotic therapy in 56,000 patients with atrial fibrillation at risk of stroke announced - For non-US, UK & Canadian Media
19.04.2012 Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*) - For media outside of the U.S.A. only
19.04.2012 First ever data investigating interferon-free treatment in hepatitis C patients who have liver cirrhosis shows high viral cure rate - For media outside of the U.S.A. only
18.04.2012 Leading medical and patient organisations join forces to improve stroke prevention in atrial fibrillation - For NON-US and NON-UK Media Only
18.04.2012 Dabigatran etexilate (Pradaxa®) associated with significantly lower rates of fatal and traumatic intracranial haemorrhage compared with Warfarin - For Non-US, UK & Canadia Media Only
16.03.2012 Pradaxa® (dabigatran etexilate) – first new oral anticoagulant in nearly 60 years receives final NICE recommendation for stroke prevention in atrial fibrillation in the UK 1 - For NON-US, NON-UK & NON- Canadian Healthcare Media Only
12.03.2012 Boehringer Ingelheim sets up its first Asian Veterinary Research & Development Center in Shanghai
02.03.2012 Porcine circovirus research projects from France and Spain awarded
29.02.2012 Boehringer Ingelheim expands capabilities in biopharmaceutical process science
21.02.2012 Boehringer Ingelheim and Xencor Enter a Collaboration Agreement for the Development, Manufacture, and Supply of Biosuperior Monoclonal Antibodies
03.02.2012 Boehringer Ingelheim, GWT and the TU Dresden sign diabetes research collaboration
31.01.2012 FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adults with Type 2 Diabetes - For Non-U.S. and Non-UK Media
26.01.2012 Boehringer Ingelheim launches ‘Lean-to-Clinic’ program for fast drug product supply
26.01.2012 Boehringer Ingelheim Moves into Phase III for its Head and Neck Cancer Trial Programme for Afatinib* - FOR NON-US MEDIA ONLY
14.12.2011 Boehringer Ingelheim significantly expands its supply center for China
09.12.2011 Boehringer Ingelheim completes patient entry for Phase III trial
programme in Hepatitis C - For media outside the U.S.
back12345678910111213141516
back to top

Media Contact

Media Contact
Our media contacts

Further Media Channels

Other News & Press Releases